08048035968
Mytera 250 mg Tablet UK Wholesale – Liverpool | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Mytera 250 mg Tablet is an oncology medicine containing Abiraterone Acetate 250 mg. It belongs to the class of androgen-biosynthesis inhibitors and is primarily used as hormone therapy for advanced or metastatic prostate cancer. It reduces the production of androgens that can stimulate prostate cancer cells.

Brand: Mytera
Strength: 250 mg
Active ingredient: Abiraterone Acetate 250 mg
Dosage form: Oral tablet
Therapeutic category: Antineoplastic / hormonal anticancer medicine
Manufacturer/Marketer: Mylan Pharmaceuticals Pvt. Ltd., a Viatris company

2. Product Information

Mytera 250 mg is available as an oral tablet, including packs of 60 and 120 tablets depending on the market. It is a prescription medicine and should be used under the supervision of an oncologist or qualified healthcare professional.

The active ingredient, abiraterone acetate, inhibits CYP17, an enzyme involved in androgen production. The medicine is generally used together with a corticosteroid such as prednisone/prednisolone as prescribed by the treating physician.

3. Uses of Mytera 250 mg Tablet

Mytera 250 mg is used for the treatment of advanced/metastatic prostate cancer, including specific forms such as metastatic castration-resistant and metastatic castration-sensitive prostate cancer, according to the treatment plan established by the physician.

It helps reduce androgen production and thereby reduces hormonal stimulation of prostate cancer cells.

4. Benefits of Mytera 250 mg Tablet

The potential therapeutic benefits include:

  • Helps reduce androgen production in the body.
  • Helps slow the growth and progression of androgen-dependent prostate cancer.
  • Can form part of hormone-based treatment for advanced prostate cancer.
  • May be used alongside other prescribed cancer treatments.
  • Oral tablet formulation can provide convenient administration when prescribed appropriately.

Important: Benefits depend on the patient's cancer type, stage, previous treatment and overall medical condition.

5. Side Effects of Mytera 250 mg Tablet

Possible side effects can include:

  • Nausea or vomiting
  • Diarrhoea
  • Fatigue
  • Headache
  • Joint pain or swelling
  • Muscle weakness
  • Hot flushes
  • Increased blood glucose
  • Fluid retention/edema
  • Changes in potassium levels
  • Increased blood pressure
  • Liver-related abnormalities

Some reactions can be serious. Symptoms such as yellowing of the skin or eyes, dark urine, severe weakness, significant swelling, breathing difficulty or other unusual symptoms require prompt medical attention.

6. Common Side Effects

Reported/common adverse effects include:

  • Fatigue
  • Nausea
  • Vomiting
  • Diarrhoea
  • Headache
  • Joint discomfort
  • Hot flushes
  • Muscle weakness
  • Edema
  • Changes in potassium levels

Not every patient experiences these effects, and their severity can vary.

7. How to Use Mytera 250 mg

Mytera should be taken exactly according to the oncologist's prescription.

  • Take the tablet orally with water.
  • Swallow it whole; do not crush, chew or break it.
  • It should generally be taken on an empty stomach.
  • Follow the prescribed timing carefully because taking abiraterone with food can substantially increase its exposure and may increase adverse effects.
  • Do not change the dose or discontinue treatment without consulting the treating physician.
  • It is commonly prescribed with prednisone/prednisolone as part of the treatment regimen.

8. How Mytera 250 mg Works

Mytera contains abiraterone acetate, which blocks the CYP17 enzyme involved in androgen production.

By inhibiting this enzyme, the medicine reduces androgen production from the testes, adrenal glands and within prostate cancer tissue. Since some prostate cancers use androgens to grow, lowering these hormone levels can help slow cancer growth and progression.

9. Safety Advice

  • Prescription use: Use only under specialist medical supervision.
  • Liver disease: Tell your doctor about existing or previous liver problems.
  • Heart conditions: Inform your doctor about cardiovascular disease, hypertension or fluid-retention problems.
  • Potassium: Regular monitoring may be required because abiraterone can affect potassium levels.
  • Blood pressure: Blood pressure should be monitored during treatment.
  • Liver function: Doctors may perform periodic liver-function tests.
  • Drug interactions: Inform the doctor about all prescription medicines, OTC medicines and supplements.
  • Pregnancy: Abiraterone can cause fetal harm; women who are pregnant or may become pregnant should not handle tablets unless appropriate precautions are followed. Effective contraception is important where applicable.
  • Children: It is not intended for routine use in children.
  • Food: Do not take with food unless specifically instructed by the treating physician.

10. FAQs

Q1. What is Mytera 250 mg Tablet used for?
It is used as part of treatment for advanced/metastatic prostate cancer.

Q2. What is the active ingredient in Mytera 250 mg?
It contains Abiraterone Acetate 250 mg.

Q3. Is Mytera a chemotherapy medicine?
It is generally classified as a hormonal/androgen-biosynthesis inhibitor, rather than conventional cytotoxic chemotherapy.

Q4. Can Mytera be taken with food?
It is generally taken on an empty stomach. Food can significantly increase abiraterone exposure, so follow the prescribed administration instructions carefully.

Q5. Can I stop Mytera when I feel better?
No. Do not stop or change cancer treatment without consulting your oncologist.

Q6. Does Mytera need to be taken with another medicine?
Abiraterone is commonly used with a corticosteroid such as prednisone/prednisolone; the exact regimen must be determined by the treating physician.

Q7. Does Mytera require monitoring?
Yes. Blood pressure, potassium and liver function may need regular monitoring during treatment.

11. Substitutes for Mytera 250 mg

Potential alternatives containing the same active ingredient and strength include brands such as:

  • Abirapro 250 mg
  • Xbira 250 mg
  • Ahabir 250 mg
  • Abitate 250 mg
  • Other locally approved Abiraterone Acetate 250 mg products

A substitute should not be selected solely on the brand name or price. The physician/pharmacist should confirm that the active ingredient, strength, formulation and treatment indication are appropriate.

12. SEO & B2B Keywords

For Phoenix Exim – Pharmaceutical Exporter from Nagpur, India, suitable informational/B2B keywords include:

  1. Mytera 250 mg Tablet exporter from India
  2. Mytera 250 mg Tablet supplier India
  3. Mytera 250 mg Abiraterone Acetate supplier
  4. Abiraterone Acetate 250 mg tablets exporter
  5. Mytera 250 mg pharmaceutical exporter
  6. Mytera 250 mg wholesale supplier India
  7. Mytera 250 mg oncology medicine supplier
  8. Mytera 250 mg prostate cancer medicine
  9. Abiraterone 250 mg tablet exporter from Nagpur
  10. Mytera 250 mg medicine supplier Nagpur
  11. Abiraterone Acetate 250 mg B2B supplier
  12. Mytera 250 mg tablets for international pharmaceutical supply
  13. Mytera 250 mg supplier for USA
  14. Mytera 250 mg supplier for UK
  15. Mytera 250 mg supplier for Australia
  16. Mytera 250 mg supplier for Singapore
  17. Mytera 250 mg supplier for Canada
  18. Mytera 250 mg supplier for South Korea
  19. Mytera 250 mg supplier for UAE
  20. Abiraterone Acetate oncology medicine exporter India
  21. Prostate cancer medicine exporter from India
  22. Generic oncology medicine supplier India
  23. Pharmaceutical export company Nagpur India
  24. Trusted pharmaceutical exporter India
  25. Oncology medicine B2B supplier India
  26. Abiraterone tablets wholesale pharmaceutical supplier
  27. Mytera Abiraterone 250 mg tablet supplier
  28. Indian pharmaceutical medicine exporter Nagpur
  29. Advanced prostate cancer medicine supplier
  30. Abiraterone Acetate 250 mg international supplier
Aug 12th, 2026 3:08 PM

Keywords